Iressa Versus Docetaxel (Taxotere)

NCT00076388 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1440

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Carcinoma

Interventions

DRUG: Gefitinib
DRUG: Docetaxel

Sponsor

AstraZeneca